| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bceb71676971f1383ae2a7e5ccaa7da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
| filingDate |
2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6c6d9ab06310f14f874b03c38b01d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b328d07d8cd20334357ea5b9ccb003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_878292b7c43d73c4a3cd776480ae6fc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d543f94689d67f1cc92361c5285361 |
| publicationDate |
2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150021993-A |
| titleOfInvention |
Crystalline forms of an androgen receptor modulator |
| abstract |
The present disclosure relates to a pharmaceutical composition comprising androgen receptor modulator 4- [7- (6-cyano-5-trifluoromethylpyridin-3- yl) -8-oxo-6-thioxo-5,7-diazaspiro [3.4] -5-yl] -2-fluoro-N-methylbenzamide is described. Also described are pharmaceutical compositions suitable for administration to mammals including androgen receptor modulators and methods of using androgen receptor modulators alone and in combination with other compounds to treat diseases and conditions associated with androgen receptor activity. |
| priorityDate |
2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |